http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0970948-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
filingDate 1998-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_865cba80fce9a72d3068fd3fff2d8c38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af077c7d9d9674b4ad64a0c88ceaed0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f054db3b6d5b3226204dd3ac641ed0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624809e438e239889ddfb688f6636bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e6b67f2313717461074e54fa74b52ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd19df5aeb35de251f14212d4ae8631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c7c27a319d361fa19151221c3676d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520b9cd7b131ee4f1cb8e81827df580c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_701b5c429e48c4e5ad973b86bfda146b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb67d54bf91dc05057e6f0f3acb1256a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b83d8d1c11719f94e66dab422a76c3
publicationDate 2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0970948-A4
titleOfInvention VITAMIN-D3? DERIVATIVES AND MEDICINAL PRODUCTS CONTAINED THEREOF FOR INFLAMMABLE DISEASES OF THE BREATHWAYS
abstract Provided are vitamin D3 derivatives expressed by the following general formula Ä1Ü <CHEM> Äwherein, R1 and R2 are each a hydrogen atom, a trialkylsilyl group, an acetyl group, a methoxymethyl group, or a tetrahydropyranyl group; R3 and R4 are each a hydrogen atom, a hydroxyl group, an acyloxy group, an alkyloxy group, an alkylthio group or an alkyl group which is optionally substituted; R5, R6, R7 and R8 are each a hydrogen atom, a hydroxyl group, an alkyl group or an acyloxy group; R9 is a hydrogen atom, a hydroxyl group, an alkyl group or an alkylthio group; R10 is a hydrogen atom, an alkyl group or an alkyloxy group; A and B are each a hydrogen atom, a hydroxyl group, or together express a single bond; X and Y express a carbonyl oxygen, or one of them is a hydrogen atom and the other is a hydroxyl group or an acyloxy group; n is an integer of 0 to 2; m is an integer of 0 to 2Ü, and a method for manufacturing the derivatives. The compounds can be sued as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis and dermatitis.
priorityDate 1997-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2260904-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8910351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9514662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0712843-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406009

Total number of triples: 34.